Skip to content

Category: Uncategorized

Chris Blattman on RCTs in Development Economics

Although I had seen the Glennerster and Kremer article in the Boston Review last week, I had saved it for later, as I was planning on reading it carefully so as to possibly assign it as an introductory reading in the development seminar I teach in the fall.

In a recent blog post, Chris Blattman has excellent thoughts on the article and on randomized controlled trials (RCTs) in general:

Is China the New Japan?

I grew up in the 1980s and the 1990s. Back then, cultural references to the superiority of the Japanese economic model where everywhere. Most of William Gibson’s Neuromancer takes place in Japan’s Chiba prefecture, which had become a suburb of Tokyo populated with expatriates much like New York or London are today. In John McTiernan’s “Die Hard,” a team of terrorists hijacks the Nakatomi Corporation’s office building in downtown Los Angeles in an effort to steal $640 million in bearer bonds. The first time I visited the United States on my own in 1996, I met people my age who were learning Japanese in college, “to do business with Japan.”

In short, if you grew up in the 1980s and 1990s, some part of your mind probably still equates “Japan” with “economic might.”